Search Results

There are 15691 results for: content related to: α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count

    Hepatology Research

    Volume 44, Issue 8, August 2014, Pages: 829–836, Naoto Ikeda, Hiroyasu Imanishi, Nobuhiro Aizawa, Hironori Tanaka, Yoshinori Iwata, Hirayuki Enomoto, Masaki Saito, Hiroko Iijima, Yuji Iimuro, Jiro Fujimoto, Satoshi Yamamoto, Shozo Hirota, Masatoshi Kudo, Shigeki Arii and Shuhei Nishiguchi

    Version of Record online : 7 AUG 2013, DOI: 10.1111/hepr.12184

  3. You have free access to this content
    Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy

    Hepatology Research

    Volume 45, Issue 2, February 2015, Pages: 152–161, Naoki Hiramatsu, Tsugiko Oze and Tetsuo Takehara

    Version of Record online : 14 OCT 2014, DOI: 10.1111/hepr.12393

  4. Recent topics on α-fetoprotein

    Hepatology Research

    Volume 43, Issue 8, August 2013, Pages: 820–825, Kazuhiko Nakao and Tatsuki Ichikawa

    Version of Record online : 25 JAN 2013, DOI: 10.1111/hepr.12052

  5. Abstract of Papers Submitted to the American Association of the Study of Liver Disease

    Hepatology

    Volume 22, Issue S4, October 1995, Pages: S107–S514,

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840220703

  6. Efficacy and safety of interferon treatment in elderly patients with chronic hepatitis C in Japan: A retrospective study using the Japanese Interferon Database

    Hepatology Research

    Volume 45, Issue 8, August 2015, Pages: 829–836, Izumi Sato, Takuro Shimbo, Yohei Kawasaki, Masashi Mizokami and Naohiko Masaki

    Version of Record online : 14 OCT 2014, DOI: 10.1111/hepr.12419

  7. Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients

    Hepatology Research

    Volume 46, Issue 8, July 2016, Pages: 758–764, Eisuke Miyaki, Michio Imamura, Nobuhiko Hiraga, Eisuke Murakami, Tomokazu Kawaoka, Masataka Tsuge, Akira Hiramatsu, Yoshiiku Kawakami, Hiroshi Aikata, C. Nelson Hayes and Kazuaki Chayama

    Version of Record online : 16 FEB 2016, DOI: 10.1111/hepr.12621

  8. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  9. Effects of antiviral therapy for hepatitis C following treatment of hepatocellular carcinoma: survey findings of the Japanese Red Cross Liver Study Group

    Hepatology Research

    Volume 46, Issue 4, April 2016, Pages: 251–258, Kouji Joko, Tohru Goto, Hiroshi Watanabe, Akari Mitsuda, Yasushi Uchida, Chitomi Hasebe, Shotaro Tsuruta, Hiroyuki Kimura, Takero Koike, Takuji Akamatsu, Toshie Mashiba, Hironori Ochi, Yoshiko Nakamura, Kaoru Tsuchiya, Masayuki Kurosaki and Namiki Izumi

    Version of Record online : 24 MAR 2015, DOI: 10.1111/hepr.12515

  10. Progressive fibrosis significantly correlates with hepatocellular carcinoma in patients with a sustained virological response

    Hepatology Research

    Volume 45, Issue 2, February 2015, Pages: 238–246, Yoshihiko Tachi, Takanori Hirai, Akihiro Miyata, Kei Ohara, Tadashi Iida, Youji Ishizu, Takashi Honda, Teiji Kuzuya, Kazuhiko Hayashi, Masatoshi Ishigami and Hidemi Goto

    Version of Record online : 24 APR 2014, DOI: 10.1111/hepr.12331

  11. Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C

    Hepatology Research

    Volume 40, Issue 4, April 2010, Pages: 383–392, Yuko Arima, Naoto Kawabe, Senju Hashimoto, Masao Harata, Yoshifumi Nitta, Michihito Murao, Takuji Nakano, Hiroaki Shimazaki, Kyoko Kobayashi, Naohiro Ichino, Keisuke Osakabe, Toru Nishikawa, Akihiko Okumura, Tetsuya Ishikawa and Kentaro Yoshioka

    Version of Record online : 4 MAR 2010, DOI: 10.1111/j.1872-034X.2009.00618.x

  12. Silent information regulator 1 inhibition induces lipid metabolism disorders of hepatocytes and enhances hepatitis C virus replication

    Hepatology Research

    Volume 43, Issue 12, December 2013, Pages: 1343–1351, Li-Jie Sun, Shu-Chen Li, Yong-Hua Zhao, Jian-Wu Yu, Peng Kang and Bing-Zhu Yan

    Version of Record online : 10 MAR 2013, DOI: 10.1111/hepr.12089

  13. You have free access to this content
    Polymorphisms of the core, NS3, and NS5A proteins of hepatitis C virus genotype 1b associate With development of hepatocellular carcinoma

    Hepatology

    Volume 58, Issue 2, August 2013, Pages: 555–563, Ahmed El-Shamy, Michiko Shindo, Ikuo Shoji, Lin Deng, Tadao Okuno and Hak Hotta

    Version of Record online : 14 JUN 2013, DOI: 10.1002/hep.26205

  14. You have free access to this content
    Alpha-fetoprotein: A biomarker for the recruitment of progenitor cells in the liver in patients with acute liver injury or failure

    Hepatology Research

    Volume 45, Issue 10, October 2015, Pages: E12–E20, Keisuke Kakisaka, Kojiro Kataoka, Mio Onodera, Akiko Suzuki, Kei Endo, Yoshinori Tatemichi, Hidekatsu Kuroda, Kazuyuki Ishida and Yasuhiro Takikawa

    Version of Record online : 19 DEC 2014, DOI: 10.1111/hepr.12448

  15. You have free access to this content
    On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir

    Hepatology

    Volume 59, Issue 3, March 2014, Pages: 986–995, Grace L.H. Wong, Henry L.Y. Chan, Yee-Kit Tse, Hoi-Yun Chan, Chi-Hang Tse, Angeline O.S. Lo and Vincent W.S. Wong

    Version of Record online : 30 JAN 2014, DOI: 10.1002/hep.26739

  16. Indices of initial hepatitis C virus RNA reduction rate to predict efficacy of interferon-beta followed by peginterferon plus ribavirin for genotype 1b high viral load

    Hepatology Research

    Volume 44, Issue 7, July 2014, Pages: 728–734, Hiroaki Okushin, Takeharu Yamamoto, Hiroshi Kishida, Kazuhiko Morii and Koichi Uesaka

    Version of Record online : 11 JUL 2013, DOI: 10.1111/hepr.12182

  17. Hepatitis C virus relapse was suppressed by long-term self-injection of low-dose interferon in patients with chronic hepatitis C after pegylated interferon plus ribavirin treatment

    Hepatology Research

    Volume 44, Issue 6, June 2014, Pages: 597–607, Tomoyuki Takashima, Hirayuki Enomoto, Toshiaki Ninomiya, Soo Ryang Kim, Hiroaki Okushin, Masahiko Sugano, Susumu Imoto, Yoshihiko Yano, Teruji Ooka, Yasushi Seo, Hiroshi Kasugai, Akira Muramatsu, Hisato Jomura, Soji Shimomura, Michiko Shindo, Hideji Nakamura, Nobuhiro Aizawa, Yoshinori Iwata, Masaki Saito, Hiroyasu Imanishi, Hiroko Iijma and Shuhei Nishiguchi

    Version of Record online : 30 MAY 2013, DOI: 10.1111/hepr.12153

  18. Perihepatic lymph node enlargement is a negative predictor for sustained responses to pegylated interferon-α and ribavirin therapy for Japanese patients infected with hepatitis C virus genotype 1

    Hepatology Research

    Volume 43, Issue 10, October 2013, Pages: 1005–1012, Hiromi Hikita, Kenichiro Enooku, Yumiko Satoh, Haruhiko Yoshida, Hayato Nakagawa, Ryota Masuzaki, Ryosuke Tateishi, Yoko Soroida, Mamiko Sato, Atsushi Suzuki, Hiroaki Gotoh, Tomomi Iwai, Hiromitsu Yokota, Kazuhiko Koike, Yutaka Yatomi and Hitoshi Ikeda

    Version of Record online : 29 JAN 2013, DOI: 10.1111/hepr.12061

  19. You have free access to this content
    Posters (Abstracts 264–2239)

    Hepatology

    Volume 66, Issue S1, October 2017, Pages: 149–1185,

    Version of Record online : 1 OCT 2017, DOI: 10.1002/hep.29501

  20. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880